About Kalytera Therapeutics
Kalytera Therapeutics is a company based in San Rafael (United States) founded in 2014 by David Stefansky. Kalytera Therapeutics has completed 2 acquisitions, including Salzman Group and Talent Biotech. Kalytera Therapeutics operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter San Rafael, United States
- Founders David Stefansky
- SectorsHealthcare
- Email••••••••
- Website kalytera.co
- Social LinkedIn X
- Investors
- Investments & AcquisitionsSalzman Group
& 1 more
Funding Insights of Kalytera Therapeutics
- Total Rounds 12
- First Round $100,000
(Jul 2014)
- Investors Count 1
Latest 10 of 12 funding rounds of Kalytera Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | – | Post-IPO | – | – | – |
| Oct 2019 | $96,792 | Post-IPO | – | – | – |
| Oct 2019 | $67,657 | Post-IPO | – | – | – |
| Sep 2019 | $760,000 | Post-IPO | – | – | – |
| Jan 2019 | $461,997 | Post-IPO | – | – | – |
| Dec 2017 | $4.47M | Post-IPO | – | – | – |
| Feb 2017 | $57.5M | Post-IPO | – | – | |
| Feb 2017 | $11.5M | Post-IPO | – | – | – |
| Aug 2016 | $250,750 | Post-IPO | – | – | – |
| Apr 2015 | $200,000 | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Kalytera Therapeutics
Kalytera Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include aphriafuture.ca.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | aphriafuture.ca | - |
Investor details for Kalytera Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kalytera Therapeutics
1 people are tracked at Kalytera Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
David Stefansky | Co-Founder | Leadership |
Complete people profiles for Kalytera Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kalytera Therapeutics
Kalytera Therapeutics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Salzman Group and Talent Biotech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Small molecule therapeutics for Crohn's disease are developed. | salzmangrp.com | Beverly, United States | 1996 | May 2020 | •••• | |
Cannabidiol therapies are developed to prevent and treat GvHD. | talentbiotech.com | Bnei Brak, Israel | 2014 | Jan 2017 | $10M |
Complete acquisition details for Kalytera Therapeutics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Kalytera Therapeutics
5 dated milestones of Kalytera Therapeutics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Kalytera Therapeutics is founded.
- Funding First funding round of $100K.
- Acquisition Acquires Talent Biotech.
- Acquisition Acquires Salzman Group.
- Funding Latest funding round, Post-IPO,.
Competitors of Kalytera Therapeutics
Kalytera Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zyus.com | 2018 | Saskatoon, Canada | $19.5M | – | Cannabis-derived therapeutics for multiple indications are developed. | |
| sanitygroup.com | 2011 | Berlin, Germany | $108.79M | – | Developer of cannabinoid-based pharmaceuticals and well-being products | |
| terraflos.com | 2021 | Uruguay | $8M | – | Medical cannabis products are provided based on GMP processes. | |
| avicanna.com | 2016 | Toronto, Canada | $5.94M | – | Plant-derived cannabinoid products are developed for medical and consumer uses. | |
| littlegreenpharma.com | 2016 | Perth, Australia | $1.91M | – | Manufacturer of medicinal cannabis for therapeutic use | |
| imcannabis.com | 2008 | Herzliya, Israel | – | – | Developer of medical cannabis products | |
| neocannbio.com | 2021 | Seoul, South Korea | $10.9M | – | Cannabinoid-based pharmaceuticals and production technologies are developed. | |
| gleaf.com | 2014 | Frederick, United States | $19.45M | 230 | Medical cannabis is cultivated by gLeaf for dispensary supply. |
Detailed competitors of Kalytera Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kalytera Therapeutics
Complete news archive for Kalytera Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Kalytera Therapeutics
10 companies that operate in the same segment as Kalytera Therapeutics (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | – | USD 204.24 M | 960 | |
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | – | – | |
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | – | |
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | – | 137 | |
Online platform for cannabis strains, reviews, and ratings | 2010 | Seattle, Washington, United States | USD 40.7 M | – | – | |
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | – | USD 186.16 M | 898 | |
ERP software is offered via cloud platform for cannabis operations. | 2018 | Boston, Massachusetts, United States | – | USD 110.08 M | 313 | |
Online marketplace connecting licensed cannabis vendors and dispensaries | 2015 | Chicago, Illinois, United States | USD 22.57 M | – | – | |
Enterprise software is provided for cannabis dispensary management. | 2016 | Oakland, California, United States | USD 75.5 M | USD 148.97 K | 97 | |
Proprietary medical cannabis strains are developed and offered. | 2014 | Maryland Heights, Missouri, United States | USD 156 M | – | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kalytera Therapeutics
Kalytera Therapeutics was founded in 2014.
Kalytera Therapeutics is headquartered in San Rafael, United States. It is registered at San Rafael, California, United States.
Kalytera Therapeutics was founded in 2014 in San Rafael, United States, within the biotechnology sector. Cannabinoid-based treatments are advanced for osteoporosis and bone healing applications. A range of non-psychoactive cannabinoids and endocannabinoid-like compounds is included in the portfolio, with emphasis on synthetic options for commercialization. The lead candidate, KAL671a synthetic fatty acid amide licensed from Yissum Research Development Companyis under research to support bone restoration in osteoporosis cases.
Kalytera Therapeutics's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.
Kalytera Therapeutics has made 2 acquisitions, including Salzman Group, and Talent Biotech.
Kalytera Therapeutics has 1 investor. Key investors include aphriafuture.ca.